Private Fund Information
as of 2022-03-30
| Name: |
DEERFIELD PARTNERS, L.P.
|
| Fund Type: |
Hedge Fund
|
| Private Fund ID: |
805-7799771524
|
| Form D File Number: |
021-80098
|
| Owners: |
187
|
| Minimum Investment: |
1000000
|
| Gross Asset Value: |
6547874114
|
| Insider Ownership %: |
9
|
| Parent Fund: |
DEERFIELD MANAGEMENT COMPANY, L.P. SERIES C
|
| Name(s) of Parter, Manager, Trustee, or Director |
- DEERFIELD MGMT, L.P., GENERAL PARTNER
|
deerfield partners, l.p.
345 PARK AVENUE SOUTH
NEW YORK
NY
10010
Business Phone:
212-551-1600
- NXStage Medical Inc
-
>10% Owner
(12/04/2012)
- SALIX PHARMACEUTICALS LTD DEL
-
>10% Owner
(09/08/2009)
- Hi-Tech Pharmacal Co., Inc.
-
>10% Owner
(07/19/2010)
- The Medicines Co
-
>10% Owner
(04/04/2011)
- Rigel Pharmaceuticals Inc
-
>10% Owner
(05/26/2011)
- Ista Pharmaceuticals Inc
-
>10% Owner
(05/04/2011)
- AUXILIUM PHARAMCEUTICALS INC
-
>10% Owner
(01/29/2015)
- eHealth Inc
-
>10% Owner
(04/26/2017)
- AUSPEX PHARMACEUTICALS INC COM
-
>10% Owner
(05/05/2015)
- Vanda Pharmaceuticals Inc
-
>10% Owner
(09/22/2016)
- Antares Pharma Inc
-
>10% Owner
(09/28/2015)
- Larimar Therapeutics Inc
-
Director
(09/16/2022)
- Xenoport Inc
-
>10% Owner
(02/19/2016)
- AveXis Inc
-
>10% Owner
(09/03/2015)
- Societal CDMO Inc
-
>10% Owner
(06/12/2017)
- ArTara Therapeutics Inc
-
>10% Owner
(11/30/2017)
- Catalyst Biosciences Inc
-
>10% Owner
(03/06/2018)
- Mallinckrodt Plc
-
>10% Owner
(05/09/2018)
- Anadys Pharmaceuticals Inc
-
>10% Owner
(10/18/2008)
- Par Pharmaceutical Companies Inc.
-
>10% Owner
(11/06/2008)
- Aerie Pharmaceuticals Inc
-
>10% Owner
(07/23/2018)
- Aclaris Therapeutics Inc
-
>10% Owner
(06/27/2019)
- Homology Medicines Inc
-
>10% Owner
(01/29/2020)
- Black Diamond Therapeutics, Inc.
-
>10% Owner
(02/03/2020)
- Revolution Medicines, Inc.
-
>10% Owner
(02/18/2020)
- The Oncology Institute
-
Director
(03/13/2020)
- Generation Bio Co.
-
>10% Owner
(06/16/2020)
- Nkarta, Inc.
-
>10% Owner
(07/14/2020)
- Deerfield Healthcare Technology Acquisitions Corp.
-
Director
(07/21/2020)
- Annexon, Inc.
-
>10% Owner
(07/28/2020)
- Acutus Medical, Inc.
-
Director
(06/30/2022)
- Avalanche Biotechnologies Inc
-
>10% Owner
(08/05/2014)
- Loxo Oncology Inc
-
>10% Owner
(08/06/2014)
- REGENXBIO Inc
-
>10% Owner
(09/22/2015)
- Kiniksa Pharmaceuticals Ltd
-
>10% Owner
(05/29/2018)
- Frequency Therapeutics Inc
-
>10% Owner
(10/07/2019)
- Cabaletta Bio, Inc.
-
>10% Owner
(10/24/2019)
- Schrodinger, Inc.
-
>10% Owner
(02/10/2020)
- Terns Pharmaceuticals Inc
-
>10% Owner
(02/09/2021)
- Oncorus, Inc.
-
>10% Owner
(12/28/2022)
- Werewolf Therapeutics Inc
-
>10% Owner
(05/04/2021)
- Inspire Pharmaceuticals Inc
-
>10% Owner
(04/30/2007)
- Arena Pharmaceuticals Inc
-
>10% Owner
(10/19/2007)
- Dynavax Technologies Corp
-
>10% Owner
(10/04/2006)
- Third Wave Technologies Inc
-
>10% Owner
(05/25/2006)
- DA32 Life Science Tech Acquisition Corp
-
Director
(08/05/2021)
- PepGen Inc
-
>10% Owner
(05/10/2022)
- Nuvalent Inc
-
Director
(11/03/2022)
- CalciMedica Inc
-
>10% Owner
(09/29/2020)
- TECHNOLOGY 100 INDEX FUND
-
>10% Owner
(10/26/2021)
- Ignyte Acquisition Corp
-
>10% Owner
(02/01/2020)
- Singular Genomics Systems Inc
-
>10% Owner
(06/01/2021)
- CareMax, Inc
-
Director
(06/08/2021)
- DFP HEALTHCARE ACQUISITIONS UNITS
-
>10% Owner
(11/12/2021)
- Frazier Lifesciences Acquisition Corp.
-
>10% Owner
(11/08/2022)
Active Schedule 13D and 13G events
Sign in to see
